Dyskeratosis congenita: delay in diagnosis and successful treatment of pancytopenia by bone marrow transplantation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1390173.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dyskeratosis congenita is an inherited disorder characterized by nail dystrophy, skin pigmentary changes, mucosal leukoplakia, pancytopenia and an increased incidence of malignancy. Because of a widely held view that the outcome of bone marrow transplantation in dyskeratosis congenita is poor, this treatment option is sometimes not considered when pancytopenia develops. We present a child currently doing well 3 years after bone marrow transplantation, and review the literature.
Medical subject headings
- Bone Marrow Transplantation
- Nail Diseases
- Pancytopenia
- Skin Diseases